76 related articles for article (PubMed ID: 20840221)
1. Level of evidence for therapeutic drug monitoring of taxanes.
Gerritsen-van Schieveen P; Royer B;
Fundam Clin Pharmacol; 2011 Aug; 25(4):414-24. PubMed ID: 20840221
[TBL] [Abstract][Full Text] [Related]
2. [Level of evidence for therapeutic drug monitoring for docetaxel].
Gerritsen-van Schieveen P; Royer B;
Therapie; 2010; 65(3):201-6. PubMed ID: 20699071
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
Justesen US
Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
[TBL] [Abstract][Full Text] [Related]
4. [Level of evidence for therapeutic drug monitoring for paclitaxel].
Gerritsen-van Schieveen P; Royer B;
Therapie; 2010; 65(3):195-200. PubMed ID: 20699070
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the taxanes including nab-paclitaxel.
Joerger M
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):691-702. PubMed ID: 25394848
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring for the individualization of docetaxel dosing: a randomized pharmacokinetic study.
Engels FK; Loos WJ; van der Bol JM; de Bruijn P; Mathijssen RH; Verweij J; Mathot RA
Clin Cancer Res; 2011 Jan; 17(2):353-62. PubMed ID: 21224369
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel.
Andriguetti NB; Raymundo S; Antunes MV; Perassolo MS; Verza SG; Suyenaga ES; Linden R
Curr Med Chem; 2017; 24(33):3559-3582. PubMed ID: 28641556
[TBL] [Abstract][Full Text] [Related]
8. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic drug monitoring (TDM): definitions--vocabulary and concepts].
Billaud EM
Therapie; 2001; 56(3):239-43. PubMed ID: 11475801
[TBL] [Abstract][Full Text] [Related]
10. [Level of evidence for therapeutic drug monitoring for etoposide after oral administration].
Schieveen PG; Hulin A; Muret P; Royer B;
Therapie; 2010; 65(3):207-12. PubMed ID: 20699072
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.
Jabir RS; Naidu R; Annuar MA; Ho GF; Munisamy M; Stanslas J
Pharmacogenomics; 2012 Dec; 13(16):1979-88. PubMed ID: 23215890
[TBL] [Abstract][Full Text] [Related]
12. Level of evidence for therapeutic drug monitoring for etoposide after oral administration.
Gerritsen-van Schieveen P; Royer B;
Fundam Clin Pharmacol; 2011 Jun; 25(3):277-82. PubMed ID: 20608987
[TBL] [Abstract][Full Text] [Related]
13. Role of TDM-based dose adjustments for taxane anticancer drugs.
Muth M; Ojara FW; Kloft C; Joerger M
Br J Clin Pharmacol; 2021 Feb; 87(2):306-316. PubMed ID: 33247980
[TBL] [Abstract][Full Text] [Related]
14. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
[TBL] [Abstract][Full Text] [Related]
15. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
Herceg D; Vrbanec D
Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Schieveen PG; Royer B;
Therapie; 2010; 65(3):201-6. PubMed ID: 27392987
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer.
Wenzel C; Locker GJ; Pluschnig U; Zielinski CC; Rudas M; Oberhuber G; Gnant MF; Taucher S; Jakesz R; Steger GG
Cancer Chemother Pharmacol; 2002 Aug; 50(2):155-9. PubMed ID: 12172982
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane.
Singer JW
J Control Release; 2005 Dec; 109(1-3):120-6. PubMed ID: 16297482
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
